Carol Prives

Carol L. Prives is the Da Costa Professor of Biological Sciences at Columbia University.[1] She is known for her work in the characterization of p53, an important tumor suppressor protein frequently mutated in cancer.

Prives received her BS and PhD in 1966[2] from McGill University, doing research in the lab of Juda Hirsch Quastel.[3] She did postdoctoral fellowships at Albert Einstein College of Medicine and the Weizmann Institute.[1]

In 1995, she was appointed as the Da Costa Professor of Biology at Columbia University.[2] She was the chair of the Department of Biological Sciences from 2000 to 2004.[4]

Prives has served as chair of the Experimental Virology and the Cell and Molecular Pathology study sections of the National Institutes of Health. She has been a member of the Scientific Advisory Boards of the Dana–Farber Cancer Institute, the Memorial Sloan Kettering Cancer Center, the Massachusetts General Cancer Center, the National Cancer Institute,[1] and the Weizmann Institute.[4] She was a member of the board of directors of the American Association for Cancer Research from 2004 to 2007.

She is a member of the editorial boards of Cell,[5] Oncogene[6] and the Proceedings of the National Academy of Sciences.[7]